This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
September 2026 quarter profit rises 23% despite nearly flat total income
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 10.4 pts less than Nifty Microcap 250 and 10.0 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the quarter ended September 30, 2026, healthcare revenue rose to Rs 10.92 lakh from Rs 9.17 lakh. Total income was nearly flat at Rs 62.50 lakh versus Rs 63.04 lakh, while expenses fell to Rs 45.24 lakh from Rs 49.03 lakh. Net profit rose 23.1% to Rs 14.03 lakh; earnings per share was Rs 0.28. Rent and other income dominate revenue. The auditor found no material misstatement; half-year operating cash flow was positive at Rs 32.78 lakh.
Profit growth may support sentiment, but revenue remains dependent on rental income. Positive cash flow and almost no borrowings are strengths.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹0.11 Cr | ₹0.09 Cr | +19.1% |
| Operating profit | −₹0.34 Cr | −₹0.40 Cr | loss narrowed |
| Profit after tax | ₹0.14 Cr | ₹0.11 Cr | +23.1% |
| EBITDA margin | -292.9% | -406.5% | +113.7 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.